You are here

  • Home
  • Archive
  • Volume 103, Issue Suppl 5
  • 45 Rivaroxaban vs. dabigatran or warfarin in real-world observational studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis

Article info

Article menu

Download PDFPDF

Cardiac Rhythm Management
45 Rivaroxaban vs. dabigatran or warfarin in real-world observational studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis
Free

Authors

Citation

Bai Y, Deng H, Shantsila A, et al
45 Rivaroxaban vs. dabigatran or warfarin in real-world observational studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis
Heart 2017;103:A36-A37.

Publication history

  • First published June 5, 2017.
Online issue publication 
June 05, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions